Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Jennifer Michelle Trujillo

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Administration
Phone303/724-2624

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Johnson EL, Frias JP, Trujillo JM. Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgrad Med. 2018 May; 130(4):365-374. PMID: 29569978.
      View in: PubMed
    2. Pearson SM, Trujillo JM. Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements. Ther Adv Endocrinol Metab. 2018 Apr; 9(4):113-121. PMID: 29619208.
      View in: PubMed
    3. Nuffer W, Guesnier A, Trujillo JM. A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products. Ther Adv Endocrinol Metab. 2018 Mar; 9(3):69-79. PMID: 29492243.
      View in: PubMed
    4. Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2018 Mar; 130(2):229-238. PMID: 29260929.
      View in: PubMed
    5. Trujillo JM, Goldman J. Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes. Pharmacotherapy. 2017 Aug; 37(8):927-943. PMID: 28556176.
      View in: PubMed
    6. Goldman J, Trujillo JM. iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes. Ann Pharmacother. 2017 Nov; 51(11):990-999. PMID: 28645216.
      View in: PubMed
    7. Saseen JJ, Linnebur SA, Borgelt LM, Trujillo J, Fish DN, Mueller S. A Pharmacotherapy Capstone Course to Target Student Learning and Programmatic Curricular Assessment. Am J Pharm Educ. 2017 Apr; 81(3):45. PMID: 28496265.
      View in: PubMed
    8. Haines ST, Pittenger AL, Stolte SK, Plaza CM, Gleason BL, Kantorovich A, McCollum M, Trujillo JM, Copeland DA, Lacroix MM, Masuda QN, Mbi P, Medina MS, Miller SM. Core Entrustable Professional Activities for New Pharmacy Graduates. Am J Pharm Educ. 2017 02 25; 81(1):S2. PMID: 28289312.
      View in: PubMed
    9. Trujillo JM, Nuffer WA. Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes. Pharmacotherapy. 2017 Apr; 37(4):481-491. PMID: 28102030.
      View in: PubMed
    10. Trujillo JM, McNair CD, Linnebur SA, Valdez C, Trujillo TC. The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes. Am J Pharm Educ. 2016 Dec 25; 80(10):174. PMID: 28179723.
      View in: PubMed
    11. Haines ST, Gleason BL, Kantorovich A, McCollum M, Pittenger AL, Plaza CM, Stolte SK, Trujillo JM. Report of the 2015-2016 Academic Affairs Standing Committee. Am J Pharm Educ. 2016 Nov 25; 80(9):S20. PMID: 28090115.
      View in: PubMed
    12. Trujillo JM, Wettergreen SA, Nuffer WA, Ellis SL, McDermott MT. Cardiovascular Outcomes of New Medications for Type 2 Diabetes. Diabetes Technol Ther. 2016 12; 18(12):749-758. PMID: 27835045.
      View in: PubMed
    13. Anderson SL, Trujillo JM. Basal Insulin Use With GLP-1 Receptor Agonists. Diabetes Spectr. 2016 Aug; 29(3):152-60. PMID: 27574369; PMCID: PMC5001217 [Available on 08/01/17].
      View in: PubMed, PubMed Central
    14. Thompson AM, Trujillo JM. Advances in the treatment of type 2 diabetes: impact of dulaglutide. Diabetes Metab Syndr Obes. 2016; 9:125-36. PMID: 27217788; PMCID: PMC4861603.
      View in: PubMed, PubMed Central
    15. Nuffer W, Trujillo JM, Megyeri J. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Ann Pharmacother. 2016 May; 50(5):376-88. PMID: 26887340.
      View in: PubMed
    16. Anderson SL, Trujillo JM. Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. Ther Adv Chronic Dis. 2016 Jan; 7(1):4-17. PMID: 26770666; PMCID: PMC4707429.
      View in: PubMed, PubMed Central
    17. Nuffer WA, Trujillo JM. Liraglutide: A New Option for the Treatment of Obesity. Pharmacotherapy. 2015 Oct; 35(10):926-34. PMID: 26497479.
      View in: PubMed
    18. Trujillo JM, Figler TA. Teaching and learning health literacy in a doctor of pharmacy program. Am J Pharm Educ. 2015 Mar 25; 79(2):27. PMID: 25861108; PMCID: PMC4386748.
      View in: PubMed, PubMed Central
    19. Hildreth KL, Van Pelt RE, Moreau KL, Grigsby J, Hoth KF, Pelak V, Anderson CA, Parnes B, Kittelson J, Wolfe P, Nakamura T, Linnebur SA, Trujillo JM, Aquilante CL, Schwartz RS. Effects of pioglitazone or exercise in older adults with mild cognitive impairment and insulin resistance: a pilot study. Dement Geriatr Cogn Dis Extra. 2015 Jan-Apr; 5(1):51-63. PMID: 25852732; PMCID: PMC4361908.
      View in: PubMed, PubMed Central
    20. Trujillo JM, Nuffer W, Ellis SL. GLP-1 receptor agonists: a review of head-to-head clinical studies. Ther Adv Endocrinol Metab. 2015 Feb; 6(1):19-28. PMID: 25678953; PMCID: PMC4321870.
      View in: PubMed, PubMed Central
    21. Thompson AM, Trujillo JM. Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes. Ann Pharmacother. 2015 Mar; 49(3):351-9. PMID: 25565404.
      View in: PubMed
    22. Trujillo JM, Nuffer W. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents. Pharmacotherapy. 2014 Nov; 34(11):1174-86. PMID: 25382096.
      View in: PubMed
    23. Nuffer W, Trujillo JM, Ellis SL. Technosphere insulin (Afrezza): a new, inhaled prandial insulin. Ann Pharmacother. 2015 Jan; 49(1):99-106. PMID: 25313261.
      View in: PubMed
    24. Trujillo JM, Nuffer W. Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes. Ann Pharmacother. 2014 Nov; 48(11):1494-501. PMID: 25136065.
      View in: PubMed
    25. Trujillo JM, Saseen JJ, Linnebur SA, Borgelt LM, Hemstreet BA, Fish DN. Impact of student- versus instructor-directed case discussions on student performance in a pharmacotherapy capstone course. Am J Pharm Educ. 2014 Apr 17; 78(3):56. PMID: 24761017; PMCID: PMC3996388.
      View in: PubMed, PubMed Central
    26. King WM, McDermott MT, Trujillo JM. Initial management of severe hyperglycemia in patients with type 2 diabetes: an observational study. Diabetes Ther. 2013 Dec; 4(2):375-84. PMID: 23949906; PMCID: PMC3889332.
      View in: PubMed, PubMed Central
    27. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71. PMID: 22825226.
      View in: PubMed
    28. DiVall M, Barr J, Gonyeau M, Matthews SJ, Van Amburgh J, Qualters D, Trujillo J. Follow-up assessment of a faculty peer observation and evaluation program. Am J Pharm Educ. 2012 May 10; 76(4):61. PMID: 22611270; PMCID: PMC3355281.
      View in: PubMed, PubMed Central
    29. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9. PMID: 20371755.
      View in: PubMed
    30. Trujillo J. A drug interactions elective course. Am J Pharm Educ. 2009 Jul 10; 73(4):72. PMID: 19657505; PMCID: PMC2720368.
      View in: PubMed, PubMed Central
    31. Trujillo JM, Hardy Y. A Nutrition Journal and Diabetes Shopping Experience to improve pharmacy students' empathy and cultural competence. Am J Pharm Educ. 2009 Apr 07; 73(2):37. PMID: 19513175; PMCID: PMC2690890.
      View in: PubMed, PubMed Central
    32. Trujillo JM, DiVall MV, Barr J, Gonyeau M, Van Amburgh JA, Matthews SJ, Qualters D. Development of a peer teaching-assessment program and a peer observation and evaluation tool. Am J Pharm Educ. 2008 Dec 15; 72(6):147. PMID: 19325963; PMCID: PMC2661155.
      View in: PubMed, PubMed Central
    33. Gonyeau MJ, Trujillo J, DiVall M. Development of progressive oral presentations in a therapeutics course series. Am J Pharm Educ. 2006 Apr 15; 70(2):36. PMID: 17139337; PMCID: PMC1636917.
      View in: PubMed, PubMed Central
    Trujillo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (104) concept(s)
    _
    Co-Authors Expand Description
    See all (20) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)